Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Clinical trial NCT02903914 · COMPLETED

Trial details

NCT number: NCT02903914
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Cancer Solid Tumors Colorectal Cancer (CRC)Gastric Cancer Head and Neck Cancer Lung Cancer Renal Cell Carcinoma (RCC)Bladder Cancer UC (Urothelial Cancer)Mesothelioma

Start date: 2016-09-14
Primary completion: 2020-04-30
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.